iRhythm Holdings, Inc.
IRTC
Positions held
Your positionsIRTC isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- iRhythm Holdings operates in the growing medical devices sector, focusing on innovative cardiac monitoring solutions that cater to an increasing demand for remote patient monitoring.
- Revenue increased by 12% compared to the prior quarter, reaching $224 million.
- Gross margin improved to 72.8%, up from 70.9% in the previous quarter.
- The company faces significant financial challenges, with a net income of -$123.406 million in 2023 and a negative profit margin of -1.69%.
- Operating margin remains low, with a recent quarter showing an expansion to only 5.1%.
- The stock has a strong sell signal with a score of -30.00, indicating bearish market sentiment.
Fundamentals
| Market cap | $3.38B | Enterprise value | $3.52B | Trailing P/E | — | Forward P/E | 80.06 |
| PEG | — | Price / book | 18.18 | Beta | 1.46 | Dividend yield | 0.00% |
| Revenue growth | 20.1% | Earnings growth | — | Gross margin | 71.5% | Operating margin | 7.9% |
| Profit margin | -1.7% | ROE | -9.6% | ROA | 0.6% | Debt / equity | 3.91 |
| Current ratio | 3.86 | Free cash flow | $81.83M | Analyst recommendation | strong_buy | Mean target | $173.93 |
| 52w high | $212.00 | 52w low | $100.70 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $224M | $199M | $209M | $193M | $187M | — |
| Op margin | 5.1% | -8.1% | 2.0% | -4.4% | -8.7% | — |
| Net income | -$0.4M | -$13.9M | $5.6M | -$5.2M | -$14.2M | — |
| Gross margin | 72.8% | 70.9% | 70.9% | 71.1% | 71.2% | — |
| Gross profit | $163M | $141M | $148M | $137M | $133M | — |
| Operating income | $11.4M | -$16.2M | $4.3M | -$8.4M | -$16.2M | — |
- Revenue +12% vs prior quarter ($224M vs $199M).
- Gross margin 72.8% (was 70.9% prior quarter).
- Operating margin expanded to 5.1%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $747M | $592M | $493M | $411M | — |
| Op margin | -7.1% | -19.4% | -23.2% | -21.2% | — |
| Net income | -$44.6M | -$113M | -$123M | -$116M | — |
| Gross margin | 70.6% | 68.9% | 67.3% | 68.5% | — |
| Gross profit | $527M | $408M | $332M | $282M | — |
| Operating income | -$52.9M | -$115M | -$114M | -$87.2M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · iRhythm Holdings (IRTC) Disclosed Unauthorized Access To Patient Data
2026-10-08 · 2 High-Flying Stocks to Research Further and 1 We Question
2026-10-07 · 2 Unprofitable Stocks with Competitive Advantages and 1 We Brush Off
2026-10-05 · Here's How Tempus AI is Capitalizing on AI-ECG Market Growth
2026-10-05 · 2 Cash-Producing Stocks Worth Your Attention and 1 We Avoid
2026-10-02 · iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
2026-09-23 · Butterfly Network (BFLY) Surges 22.0%: Is This an Indication of Further Gains?
2026-09-22 · Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
2026-09-21 · Firing on All Cylinders: iRhythm (NASDAQ:IRTC) Q2 Earnings Lead the Way
2026-09-04 · Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
Price (daily)
Full chart · RSI · MACD · patterns